A nanobody-based complement inhibitor targeting complement component 2 reduces hemolysis in a complement humanized mouse model of autoimmune hemolytic anemia

A nanobody-based complement inhibitor targeting complement component 2 reduces hemolysis in a complement humanized mouse model of autoimmune hemolytic anemia

Copyright © 2023 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 253(2023) vom: 01. Aug., Seite 109678
1. Verfasser: Chen, Jin Y (VerfasserIn)
Weitere Verfasser: Zhang, Lingjun, Luo, Liping, Yang, Maojing, Chen, Yinghua, Lin, Feng
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2023
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural AIHA C2 Classical pathway Complement Lectin pathway Nanobody Complement C2 Complement Inactivating Agents
Online verfügbar Volltext